Metabolon Reviews

- Poor transparency: Before COVID hit, one member of exec team told all employees there would be NO layoffs, we were just having a "short term cash flow situation". Employees were told that they "temporarily" wouldn't receive promised bonuses. Fast forward a month later, and almost half the company was put on furlough with NO warning to any middle or lower management. Fast forward one more month, and 10% of the company was laid off- again, with no warning or discussion with middle or lower management. - Low pay: Pay was really low for the work that was expected. The benefits did make up for some of it, but not all of it. - High turnover: I saw numerous turnovers of middle managers during my time there - The CEO doesn't seem to have a clue what the company is doing, scientifically or financially. It's being pulled in ten different directions at once. - HR was disastrous in handling laid off and furloughed employees. Communication and execution of this was poor to put it delicately. - Also, if you keep up with investing in biotech... Metabolon has been digging a deeper and deeper hole with loans and venture capital - Doesn't seem like the outlook is great overall

-Leadership team is blinded by arrogance, greed, and cluelessness. They refuse to understand the technology's utility, shortcomings, and especially customer base. Most that did understand have left the company. -Company business strategy seems to be incrementally making it more difficult for customers to purchase and effectively use the data that otherwise is in high demand -Lack of company vision and business strategy. Often felt like "our customers are benefiting too much from our data, that's not fair, how do we stop that?" -Incredible inertia against needed changes to be implemented. For a company of only ~200 people, feels more like government bureaucracy (or worse). When decisions were actually made, communication was poor or nonexistent. -Marketing team refuses to understand customer persona, needs, and competition, nor do they have any sense of urgency. Competition is catching up quickly, yet decisions are made slowly and seemingly in a vacuum. Recent re-branding is lipstick on a pig and still doesn't address what customers are asking. -Reaction to COVID was to lay off many scientists at a supposedly science-based company